Sorry, you need to enable JavaScript to visit this website.

Switching antipsychotics | INVEGA SUSTENNA® HCP

Transitioning From Other Antipsychotics

Before transitioning to INVEGA SUSTENNA®

Establish tolerability in patients who have not taken oral paliperidone, oral risperidone, or injectable risperidone.1 Learn about initiation and maintenance dosing for INVEGA SUSTENNA®.

Recommended dosing for adults with schizophrenia1

Tap arrows to view transitioning information

References: 1. INVEGA SUSTENNA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; July 2022. 2. Russu A, Kern Sliwa J, Ravenstijn P, et al. Maintenance dose conversion between oral risperidone and paliperidone palmitate 1 month: practical guidance based on pharmacokinetic simulations. Int J Clin Pract. 2018 Jun;72(6):e13089. 3. Samtani MN, et al. Dosing and switching strategies for paliperidone palmitate: based on population pharmacokinetic modelling and clinical trial data. CNS Drugs. 2011;25(10):829-845. doi:10.2165/11591690-000000000-00000 4. INVEGA TRINZA® [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; August 2021.